Wang X, Zhang J, Guo P, Guo Y, Yang X, Liu M
Biosaf Health. 2025; 5(6):355-362.
PMID: 40078747
PMC: 11895035.
DOI: 10.1016/j.bsheal.2023.09.002.
Correale P, Baglio G, Parrella R, Saladino R, Cuomo N, Scarano F
J Transl Med. 2025; 23(1):303.
PMID: 40065352
PMC: 11892203.
DOI: 10.1186/s12967-025-06285-w.
Mazzotti L, Borges de Souza P, Azzali I, Angeli D, Nanni O, Sambri V
HLA. 2025; 105(1):e70011.
PMID: 39807702
PMC: 11731316.
DOI: 10.1111/tan.70011.
Deng S, Xu Z, Hu J, Yang Y, Zhu F, Liu Z
Front Immunol. 2024; 15:1468456.
PMID: 39450171
PMC: 11499136.
DOI: 10.3389/fimmu.2024.1468456.
Tao S, You X, Norman P, Kichula K, Dong L, Chen N
HLA. 2024; 104(4):e15715.
PMID: 39364548
PMC: 11458138.
DOI: 10.1111/tan.15715.
The characteristic of HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB3/4/5, HLA-DQA1, HLA-DQB1, HLA-DPA1, and HLA-DPB1 alleles in Zhejiang Han population.
Tao S, You X, Chen N, Dong L, Zhao S, He Y
Immunogenetics. 2024; 76(5-6):305-314.
PMID: 39107575
DOI: 10.1007/s00251-024-01349-5.
Narrative Review Explaining the Role of , , and Molecules in COVID-19 Disease in and around Africa.
Naidoo L, Arumugam T, Ramsuran V
Infect Dis Rep. 2024; 16(2):380-406.
PMID: 38667755
PMC: 11049896.
DOI: 10.3390/idr16020029.
HLA genetic polymorphisms and prognosis of patients with COVID-19.
Lorente L, Martin M, Franco A, Barrios Y, Caceres J, Sole-Violan J
Med Intensiva. 2024; 45(2):96-103.
PMID: 38620408
PMC: 7474921.
DOI: 10.1016/j.medin.2020.08.004.
Evaluation the frequencies of HLA alleles in moderate and severe COVID-19 patients in Iran: A molecular HLA typing study.
Abolnezhadian F, Iranparast S, Shohan M, Shokati Eshkiki Z, Hamed M, Seyedtabib M
Heliyon. 2024; 10(7):e28528.
PMID: 38590857
PMC: 10999921.
DOI: 10.1016/j.heliyon.2024.e28528.
The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population.
Vica M, Dobreanu M, Curocichin G, Matei H, Balici S, Vuscan M
Int J Mol Sci. 2024; 25(2).
PMID: 38279325
PMC: 10816224.
DOI: 10.3390/ijms25021326.
The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: A global review.
Hoseinnezhad T, Soltani N, Ziarati S, Behboudi E, Mousavi M
J Clin Lab Anal. 2024; 38(1-2):e25005.
PMID: 38251811
PMC: 10829690.
DOI: 10.1002/jcla.25005.
Association of ABO blood group, Rh phenotype and MN blood group with susceptibility to COVID-19.
Lu G, Chen W, Lu Y, Yu Q, Gao L, Xin S
PLoS One. 2024; 19(1):e0296917.
PMID: 38241306
PMC: 10798469.
DOI: 10.1371/journal.pone.0296917.
The demographic, laboratory and genetic factors associated with long Covid-19 syndrome: a case-control study.
Torki E, Hoseininasab F, Moradi M, Sami R, Sullman M, Fouladseresht H
Clin Exp Med. 2024; 24(1):1.
PMID: 38231284
PMC: 10794331.
DOI: 10.1007/s10238-023-01256-1.
Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso.
Ouedraogo A, Traore L, Ouattara A, Ouedraogo A, Zongo S, Savadogo M
BMC Med Genomics. 2023; 16(1):246.
PMID: 37845715
PMC: 10577973.
DOI: 10.1186/s12920-023-01684-8.
Exploring the Immunomodulatory Properties of Stem Cells in Combating COVID-19: Can We Expect More?.
Mallis P
Bioengineering (Basel). 2023; 10(7).
PMID: 37508830
PMC: 10376782.
DOI: 10.3390/bioengineering10070803.
"HLA-C: evolution, epigenetics, and pathological implications in the major histocompatibility complex".
Velastegui E, Vera E, Vanden Berghe W, Munoz M, Orellana-Manzano A
Front Genet. 2023; 14:1206034.
PMID: 37465164
PMC: 10350511.
DOI: 10.3389/fgene.2023.1206034.
Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation.
Nabi A, Ebihara A, Shekhar H
World J Virol. 2023; 12(3):151-171.
PMID: 37396707
PMC: 10311579.
DOI: 10.5501/wjv.v12.i3.151.
COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
Malekpour M, Khanmohammadi S, Meybodi M, Shekouh D, Rahmanian M, Kardeh S
Immun Inflamm Dis. 2023; 11(5):e875.
PMID: 37249286
PMC: 10187022.
DOI: 10.1002/iid3.875.
Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics.
Ul Haq I, Krukiewicz K, Tayyab H, Khan I, Khan M, Yahya G
J Clin Med. 2023; 12(7).
PMID: 37048725
PMC: 10095019.
DOI: 10.3390/jcm12072645.
HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19.
Wang R, Sun Y, Kuang B, Yan X, Lei J, Lin Y
Emerg Microbes Infect. 2023; 12(1):2185467.
PMID: 36849422
PMC: 10013568.
DOI: 10.1080/22221751.2023.2185467.